OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine – A Prospective Observational Study
Jonas Herzberg, Bastian Fischer, Heiko Becher, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Jonas Herzberg, Bastian Fischer, Heiko Becher, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Showing 16 citing articles:
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
Laura Pérez‐Alós, Cecilie Bo Hansen, José Juan Almagro Armenteros, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 33
Laura Pérez‐Alós, Cecilie Bo Hansen, José Juan Almagro Armenteros, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 33
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
Alessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 94, Iss. 4, pp. 290-299
Open Access | Times Cited: 26
Alessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 94, Iss. 4, pp. 290-299
Open Access | Times Cited: 26
Long-term assessment of anti-SARS-CoV-2 antibody levels post-pandemic: Tracking the dynamics after two, three, and four COVID-19 vaccine doses
Fatemeh Ashrafian, Mostafa Salehi-Vaziri, Ehsan Mostafavi, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102676-102676
Open Access
Fatemeh Ashrafian, Mostafa Salehi-Vaziri, Ehsan Mostafavi, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102676-102676
Open Access
Monitoring Humoral Immune Response Following COVID-19 Immunization and Booster Dose: A Prospective Study in Tunisian Healthcare Workers
Chiraz Naffouti, Hela Hannachi, Wafa Aissi, et al.
Journal of Clinical Virology Plus (2025), pp. 100210-100210
Open Access
Chiraz Naffouti, Hela Hannachi, Wafa Aissi, et al.
Journal of Clinical Virology Plus (2025), pp. 100210-100210
Open Access
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan
Yuta Tani, Morihito Takita, Yurie Kobashi, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 920-920
Open Access | Times Cited: 8
Yuta Tani, Morihito Takita, Yurie Kobashi, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 920-920
Open Access | Times Cited: 8
Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial
Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, et al.
Vaccine (2023) Vol. 41, Iss. 32, pp. 4648-4657
Open Access | Times Cited: 8
Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, et al.
Vaccine (2023) Vol. 41, Iss. 32, pp. 4648-4657
Open Access | Times Cited: 8
SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies
Sabine Haggenburg, Quincy Hofsink, Caroline E. Rutten, et al.
Seminars in Hematology (2022) Vol. 59, Iss. 4, pp. 192-197
Open Access | Times Cited: 8
Sabine Haggenburg, Quincy Hofsink, Caroline E. Rutten, et al.
Seminars in Hematology (2022) Vol. 59, Iss. 4, pp. 192-197
Open Access | Times Cited: 8
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
Niko Kohmer, Shivana Stein, Barbara Schenk, et al.
International Journal of Infectious Diseases (2022) Vol. 128, pp. 166-175
Open Access | Times Cited: 7
Niko Kohmer, Shivana Stein, Barbara Schenk, et al.
International Journal of Infectious Diseases (2022) Vol. 128, pp. 166-175
Open Access | Times Cited: 7
Increase over time of antibody levels 3 months after a booster dose as an indication of better protection against Omicron infection
Rea Bingula, Hélène Chabrolles, Benjamin Bonnet, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Rea Bingula, Hélène Chabrolles, Benjamin Bonnet, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Effects of Omicron Infection and Changes in Serum Antibody Response to Wild-Type, Delta, and Omicron After a Booster Dose With BNT163b2 Vaccine in Korean Healthcare Workers
Sung Hee Lim, Han Jo Kim, Se Hyung Kim, et al.
Journal of Korean Medical Science (2023) Vol. 38, Iss. 13
Open Access | Times Cited: 2
Sung Hee Lim, Han Jo Kim, Se Hyung Kim, et al.
Journal of Korean Medical Science (2023) Vol. 38, Iss. 13
Open Access | Times Cited: 2
Longitudinal evaluation of innate immune responses to three doses of CoronaVac vaccine
Cheng Cao, Junfeng Jiang, Min Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Cheng Cao, Junfeng Jiang, Min Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Revaccination against COVID-19: Current Status of the Problem
N. P. Andreeva, S. R. Racic, S. V. Lezhenina, et al.
Epidemiology and Vaccinal Prevention (2024) Vol. 23, Iss. 2, pp. 94-101
Open Access
N. P. Andreeva, S. R. Racic, S. V. Lezhenina, et al.
Epidemiology and Vaccinal Prevention (2024) Vol. 23, Iss. 2, pp. 94-101
Open Access
An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results
Marzena Zalewska, Wiktoria Fus, Adam Konka, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1546-1546
Open Access | Times Cited: 2
Marzena Zalewska, Wiktoria Fus, Adam Konka, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1546-1546
Open Access | Times Cited: 2
Humoral and cellular response three months following bivalent booster administration
Julien Favresse, Constant Gillot, Jean‐Louis Bayart, et al.
Research Square (Research Square) (2023)
Open Access
Julien Favresse, Constant Gillot, Jean‐Louis Bayart, et al.
Research Square (Research Square) (2023)
Open Access
Antibody response to variants during Omicron outbreak after BNT162b2 booster in Korean healthcare workers
Sung Hee Lim, Han Jo Kim, Se Hyung Kim, et al.
Research Square (Research Square) (2022)
Open Access
Sung Hee Lim, Han Jo Kim, Se Hyung Kim, et al.
Research Square (Research Square) (2022)
Open Access
What Proportion of Population has achieved Cellular Immunity against SARS-CoV-2 after Booster Vaccination: A Cross-sectional Study
Yuta Tani, Morihito Takita, Yurie Kobashi, et al.
Research Square (Research Square) (2022)
Open Access
Yuta Tani, Morihito Takita, Yurie Kobashi, et al.
Research Square (Research Square) (2022)
Open Access
